Discovery of new selective glucocorticoid receptor agonist leads

被引：10
|
作者：
Berger, Markus [1 ]
Rehwinkel, Hartmut [1 ]
Schmees, Norbert [1 ]
Schaecke, Heike [2 ]
Edman, Karl [3 ]
Wissler, Lisa [3 ]
Reichel, Andreas [4 ]
Jaroch, Stefan [5 ]
机构：
[1] Bayer Pharma AG, Med Chem Berlin, Candidate Generat & External Innovat, Drug Discovery, D-13353 Berlin, Germany
[2] Bayer Pharma AG, Gynecol Therapies Berlin, Global Therapeut Res, Drug Discovery, D-13353 Berlin, Germany
[3] AstraZeneca, Discovery Sci, Innovat Med & Early Dev Biotech Unit, Pepparedsleden 1, S-43183 Molndal, Sweden
[4] Bayer Pharma AG, Res Pharmacokinet, Early Dev, Drug Discovery, D-13353 Berlin, Germany
[5] Bayer Pharma AG, Global External Innovat & Alliances, Candidate Generat & External Innovat, Drug Discovery, D-13353 Berlin, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2017年 / 27卷 / 03期
关键词：
Glucocorticoid; SEGRA; Transrepression; Transactivation; Tetrahydronaphthalene; Amino alcohol; LIGAND-BINDING DOMAIN; MINERALOCORTICOID RECEPTOR; INFLAMMATORY RESPONSES; CRYSTAL-STRUCTURE; MECHANISMS; IDENTIFICATION; THERAPY; RU-486; SKIN;
D O I：
10.1016/j.bmcl.2016.12.047
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report on the discovery of two new lead series for the development of glucocorticoid receptor agonists. Firstly, the discovery of tetrahydronaphthalenes led to metabolically stable and dissociated compounds. Their binding mode to the glucocorticoid receptor could be elucidated through an X-ray structure. Closer inspection into the reaction path and analyses of side products revealed a new amino alcohol series also addressing the glucocorticoid receptor and demonstrating strong anti-inflammatory activity in vitro. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：437 / 442
页数：6
相关论文
共 50 条
  • [21] Discovery of ORIC-101, a potent and selective glucocorticoid receptor antagonist
    Rew, Yosup
    Du, Xiaohui
    Eksterowicz, John
    Zhou, Haiying
    Jahchan, Nadine
    Zhu, Liusheng
    Kawai, Hiro
    Yan, Xuelei
    McGee, Lawrence
    Medina, Julio
    Huang, Tom
    Chen, Chelsea
    Zavorotinskaya, Tatiana
    Sutimantanapi, Dena
    Waszczuk, Joanna
    Jackson, Erica
    Huang, Elizabeth
    Ye, Qiuping
    Fantin, Valeria
    Sun, Daqing
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [22] Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists
    Sheppeck, James E., II
    Gilmore, John L.
    Xiao, Hai-Yun
    Dhar, T. G. Murali
    Nirschl, David
    Doweyko, Arthur M.
    Sack, Jack S.
    Corbett, Martin J.
    Malley, Mary F.
    Gougoutas, Jack Z.
    Mckay, Lorraine
    Cunningham, Mark D.
    Habte, Sium F.
    Dodd, John H.
    Nadler, Steven G.
    Somerville, John E.
    Barrish, Joel C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) : 5442 - 5447
  • [23] Beneficial Pharmacological Effects of Selective Glucocorticoid Receptor Agonist in External Eye Diseases
    Kato, Masatomo
    Hagiwara, Yumi
    Oda, Tomoko
    Imamura-Takai, Miwa
    Aono, Hiroyuki
    Nakamura, Masatsugu
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 353 - 360
  • [24] Ocular Pharmacokinetics of Mapracorat, a Novel, Selective Glucocorticoid Receptor Agonist, in Rabbits and Monkeys
    Proksch, Joel W.
    Lowe, Ezra R.
    Ward, Keith W.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (07) : 1181 - 1187
  • [25] Discovery of a potent and selective agonist of the prostaglandin EP4 receptor
    Billot, X
    Chateauneuf, A
    Chauret, N
    Denis, D
    Greig, G
    Mathieu, MC
    Metters, KM
    Slipetz, DM
    Young, RN
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1129 - 1132
  • [26] Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays
    Pang, Jin-ping
    Hu, Xue-ping
    Wang, Yun-xia
    Liao, Jia-ning
    Chai, Xin
    Wang, Xu-wen
    Shen, Chao
    Wang, Jia-jia
    Zhang, Lu-lu
    Wang, Xin-yue
    Zhu, Feng
    Weng, Qin-jie
    Xu, Lei
    Hou, Ting-jun
    Li, Dan
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (09) : 2429 - 2438
  • [27] Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays
    Jin-ping Pang
    Xue-ping Hu
    Yun-xia Wang
    Jia-ning Liao
    Xin Chai
    Xu-wen Wang
    Chao Shen
    Jia-jia Wang
    Lu-lu Zhang
    Xin-yue Wang
    Feng Zhu
    Qin-jie Weng
    Lei Xu
    Ting-jun Hou
    Dan Li
    Acta Pharmacologica Sinica, 2022, 43 : 2429 - 2438
  • [28] Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)
    Rew, Yosup
    Du, Xiaohui
    Eksterowicz, John
    Zhou, Haiying
    Jahchan, Nadine
    Zhu, Liusheng
    Yan, Xuelei
    Kawai, Hiroyuki
    McGee, Lawrence R.
    Medina, Julio C.
    Huang, Tom
    Chen, Chelsea
    Zavorotinskaya, Tatiana
    Sutimantanapi, Dena
    Waszczuk, Joanna
    Jackson, Erica
    Huang, Elizabeth
    Ye, Qiuping
    Fantin, Valeria R.
    Sun, Daqing
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (17) : 7767 - 7784
  • [29] Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist
    Jiang, Weiqin
    Fiordeliso, James J.
    Allan, George
    Linton, Olivia
    Tannenbaum, Pamela
    Xu, Jun
    Zhu, Peifang
    Gunnet, Joseph
    Demarest, Keith
    Lundeen, Scott
    Sui, Zhihua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1471 - 1474
  • [30] Effect of the Topical Selective Glucocorticoid Receptor Agonist, Mapracorat, in Experimental Dry Eye Disease
    Eiglmeier, Susanne
    Sadrai, Zahra
    Chen, Yihe
    Chauhan, Sunil K.
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345